NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associ...

Full description

Saved in:
Bibliographic Details
Main Authors PINTO PATRICK A, ARASAPPAN ASHOK, HUANG YUHUA, WANG HAIYAN, GANGULY ASHIT K, VACCARO HENRY A, HENDRATA SISKA, BOGEN STEPHANE L, ZHU ZHAONING, WU WANLI, TAMURA SUSAN Y, CHAN TIN-YAU, SAKSENA ANIL K, BENNETT FRANK, JAO EDWIN E, LEVY ODILE ESTHER, NJOROGE F.GEORGE, SANTHANAM BAMA, VENKATRAMAN SRIKANTH, PAREKH TEJAL N, GIRIJAVALLABHAN VIYYOOR MOOPIL, PIKE RUSSELL E, KEMP SCOTT JEFFREY, LOVEY RAYMOND G, LIM-WILBY MARGUERITA, CHEN KEVIN X, MC CORMICK JINPING L, LIU YI-TSUNG
Format Patent
LanguageEnglish
Polish
Published 30.07.2010
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Bibliography:Application Number: PL20010366063